Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serotonin and vascular disease: a survey.

Literature DB >> 2285645

Serotonin and vascular disease: a survey.

J I Robertson¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Serotonin

Year: 1990 PMID： 2285645 DOI： 10.1007/bf00053446

Source DB: PubMed Journal: Cardiovasc Drugs Ther ISSN： 0920-3206 Impact factor: 3.727

Keyword Cloud
References

× No keyword cloud information.

25 in total

1. Free serotonin in human plasma. Quantitative and qualitative estimation.

Authors: J I ROBERTSON; T M ANDREWS
Journal: Lancet Date: 1961-03-18 Impact factor: 79.321

2. The effect of a serotonin antagonist (UML 491) in carcinoid disease.

Authors: W S PEART; J I ROBERTSON
Journal: Lancet Date: 1961-11-25 Impact factor: 79.321

Review 3. Central serotonergic mechanisms in cardiovascular regulation.

Authors: J Minson; J Chalmers; G Drolet; V Kapoor; I Llewellyn-Smith; E Mills; M Morris; P Pilowsky
Journal: Cardiovasc Drugs Ther Date: 1990-01 Impact factor: 3.727

4. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect.

Authors: T C Naslund; W J Merrell; J H Nadeau; A J Wood
Journal: Clin Pharmacol Ther Date: 1988-12 Impact factor: 6.875

5. Loss of 5-hydroxytryptamine from mammalian circulating labelled platelets.

Authors: E E Osim; J H Wyllie
Journal: J Physiol Date: 1983-07 Impact factor: 5.182

Review 6. Portal hypertension: serotonin and pathogenesis.

Authors: D Lebrec
Journal: Cardiovasc Drugs Ther Date: 1990-01 Impact factor: 3.727

Review 7. The role of serotonin in the preeclampsia-eclampsia syndrome.

Authors: C P Weiner
Journal: Cardiovasc Drugs Ther Date: 1990-01 Impact factor: 3.727

Review 8. Serotonin and acute cardiovascular disorders.

Authors: R S Reneman; P J van der Starre
Journal: Cardiovasc Drugs Ther Date: 1990-01 Impact factor: 3.727

Review 9. Serotonergic antagonists and vascular disease.

Authors: P M Vanhoutte
Journal: Cardiovasc Drugs Ther Date: 1990-01 Impact factor: 3.727

10. Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.

Authors:
Journal: BMJ Date: 1989-02-18